In controlled trials of antiepileptic drugs (AEDs) seizure frequency is often the only variable considered. With little prospect of improving assessment of AEDs, using seizure counts as the only end-point, there is a need for the development of new outcome measures. Clinical experience indicates tha
Measuring the impact of epilepsy: the development of a novel scale
β Scribed by Ann Jacoby; Gus Baker; David Smith; Michael Dewey; David Chadwick
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 563 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0920-1211
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The Arthritis Impact Measurement Scales (AIMS) have been developed to assess the health status of arthritis patients. In this study, the selfβadministered AIMS questionnaire, which includes scales designed to measure the physical, psychologic, and social aspects of health status, was co
During the past decade, several scales have been developed to improve the assessment of outcome in epilepsy. These scales were developed for adults and their reliability, validity and usefulness have been established. However, there is also a need for alternative measures of outcome in childhood epi